Sovremennaya Revmatologiya

Aims & Scope

The main task of the journal "Sovremennaya revmatologiya" (“Modern Rheumatology Journal”) is to increase the level of rheumatologists’ knowledge.

The journal publishes only high-quality peer-reviewed articles: current rheumatology lectures and reviews, international and Russian clinical guidelines for the treatment of rheumatic diseases (treatment protocols), results of original investigations, interesting clinical observations, pharmacotherapy articles, organization of rheumatology services, information about symposia and conferences, and discussions.

Rheumatology is one of the most important medical disciplines; it covers a wide range of diseases, therefore the journal’s Editorial Board have brought together experts from the country’s leading research centers: V.A.

Nasonova Research Institute of Rheumatology (Moscow); Russian Medical Academy of Continuing Medical Education, Ministry of Health of Russia (Moscow); Department of Pediatrics and Pediatric Rheumatology, Research Center for Children's Health (Moscow); Pacific State Medical University (Vladivostok); Research Institute for Clinical and Experimental Rheumatology (Volgograd); Department of Hospital Pediatrics, Saint Petersburg State Pediatric Medical University (Saint Petersburg); Laboratory for Diagnosis of Autoimmune Diseases, Research and Guidance Center for Molecular Medicine (Saint Petersburg); Kemerovo State Medical Academy (Kemerovo); Professor V.F.

Voino-Yasenetsky Krasnoyarsk State Medical University (Krasnoyarsk); A.S.

Loginov Moscow Clinical Research Center (Moscow); and N.I.

Pirogov Russian National Research Medical University (Moscow).

Metrics & Ranking

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Directory of Open Access Journals (DOAJ)

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Immunology and Microbiology and Medicine, designed to support cutting-edge academic discovery.

Licensing & Copyright

This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.

Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.

Policy Links

This section provides access to essential policy documents, guidelines, and resources related to the journal’s publication and submission processes.

• Aims scope
• Homepage
• Oa statement
• Author instructions
• License terms
• Review url
• Board url
• Copyright url
• Plagiarism url
• Apc url
• License

Plagiarism Policy

This journal follows a plagiarism policy. All submitted manuscripts are screened using reliable plagiarism detection software to ensure originality and academic integrity. Authors are responsible for proper citation and acknowledgment of all sources, and any form of plagiarism, including self-plagiarism, will not be tolerated.

For more details, please refer to our official: Plagiarism Policy.

APC Details

The journal’s Article Processing Charge (APC) policies support open access publishing in Immunology and Microbiology and Medicine, ensuring accessibility and quality in research dissemination.

This journal does not charge a mandatory Article Processing Charge (APC). However, optional open access publication may incur fees based on the publisher’s policies.

Explore journals without APCs for alternative publishing options.

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Osteoarthritis: epidemiology, classification, risk factors, and progression, clinical presentation, diagnosis, and treatment

  Citation: 91

  Authors: L. I., E. A., N. G.

• Clinical guidelines «Rational use of nonsteroidal anti-inflammatory drugs (NSAIDs) in clinical practice»

  Citation: 57

  Authors: A. E., E. L., N. N., V. T., N. V., L. I., Yu. A., M. A., M. L., A. B., O. V., A. V., D. S., O. M., S. S., G. R.

• Psoriatic arthritis. Clinical guidelines for diagnosis and treatment

  Citation: 26

  Authors: T. V., Yu. L., E. Yu., E. E., M. N.

• Five-year (2013–2017) trends in the incidence and prevalence of musculoskeletal system diseases among the adult population of Russia

  Citation: 25

  Authors: R. M., T. V.

• Practical application of national clinical guidelines for the management of gout (preliminary data)

  Citation: 20

  Authors: M. N., M. S., O. V.

• Bioactive concentrate from small sea fish: evaluation of the efficacy and safety of the drug on the basis of the analysis of 37 clinical trials

  Citation: 19

  Authors: A. E.

• Assessment of organization of medical care and drug provision for patients with rheumatic diseases, and the socioeconomic burden of these diseases in the Russian Federation

  Citation: 19

  Authors: A. M., R. О., V. V.

• Draft interdisciplinary guidelines for diagnosis, methods for estimation of the degree of activity, for evaluation of therapeutic efficacy, and for use of biological agents in patients with concomitant immunoinflammatory diseases (psoriasis, psoriatic arthritis, Crohn's disease)

  Citation: 17

  Authors: D. I., A. L., E. А., L. F., T. V., L. S., M. M., A. M., V. R., I. L., M. M.

• Aceclofenac: the experience of Russian studies

  Citation: 17

  Authors: A. E., A. V.

• Current approaches to osteoarthritis phenotyping

  Citation: 17

  Authors: A. M., L. I., K. A.